Login / Signup

A Phase I, Open-Label, Mass Balance Study of [ 14 C]-Iberdomide in Healthy Subjects.

Yiming ChengXiaomin WangLiangang LiuJose SilvaMichael ThomasYan Li
Published in: European journal of drug metabolism and pharmacokinetics (2024)
NCT03294603.
Keyphrases
  • open label
  • clinical trial
  • squamous cell carcinoma
  • study protocol
  • phase ii
  • rectal cancer
  • placebo controlled